feed,title,long_url,short_url
Benzinga,Athenex Shares Are Trading Lower After FDA Rejected Oral Paclitaxel Plus Encequidar Application In Breast Cancer,https://benzinga.com/general/biotech/21/03/19908597/athenex-shares-are-trading-lower-after-fda-rejected-oral-paclitaxel-plus-encequidar-application-i,https://j.mp/2PbQFID
